Kevin Chaplin
Kevin Chaplin is the CEO of Kardium Inc., a Vancouver-based medical device company specializing in innovative treatments for atrial fibrillation. Under his leadership, Kardium has developed a groundbreaking pulsed field ablation technology and recently raised $340 million to prepare for FDA approval and market entry.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 9.00 | 0.08% | +0% | 38,005,238 | 28,748 | $1,700,000 | 1,286$ |
| Totals | 1 | 38,005,238 | 28,748 | $1,700,000 | 1,286$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Kevin Chaplin is the CEO of Kardium, which has received FDA approval for its medical device.
9
Canada:
Kevin Chaplin is the CEO of Kardium and is optimistic about receiving FDA approval for their heart device.
9